Piper Sandler says Alzheimer's treatment Leqembi will help drive the stock up 20% in coming months. Leqembi is currently awaiting full approval from the FDA.
"To us, the lukewarm usage demonstrates that VR remains 'early days' and that these devices are less important than smartphones," Piper Sandler analysts wrote.
The FDIC is aiming to sell both in their entirety, while offers for parts of the banks could be considered if whole company sales do not happen, two sources said.